335 related articles for article (PubMed ID: 18927599)
21. Heavy chain ferritin siRNA delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agents.
Liu X; Madhankumar AB; Slagle-Webb B; Sheehan JM; Surguladze N; Connor JR
Cancer Res; 2011 Mar; 71(6):2240-9. PubMed ID: 21385903
[TBL] [Abstract][Full Text] [Related]
22. Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes.
Sonoke S; Ueda T; Fujiwara K; Sato Y; Takagaki K; Hirabayashi K; Ohgi T; Yano J
Cancer Res; 2008 Nov; 68(21):8843-51. PubMed ID: 18974128
[TBL] [Abstract][Full Text] [Related]
23. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
24. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
25. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
[TBL] [Abstract][Full Text] [Related]
26. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
27. Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene‑silencing effects and siRNA biodistribution in mice.
Hattori Y; Tamaki K; Sakasai S; Ozaki KI; Onishi H
Mol Med Rep; 2020 Nov; 22(5):4183-4196. PubMed ID: 33000194
[TBL] [Abstract][Full Text] [Related]
28. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
[TBL] [Abstract][Full Text] [Related]
29. Targeting aspartate aminotransferase in breast cancer.
Thornburg JM; Nelson KK; Clem BF; Lane AN; Arumugam S; Simmons A; Eaton JW; Telang S; Chesney J
Breast Cancer Res; 2008; 10(5):R84. PubMed ID: 18922152
[TBL] [Abstract][Full Text] [Related]
30. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
31. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
[TBL] [Abstract][Full Text] [Related]
32. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium.
Santel A; Aleku M; Keil O; Endruschat J; Esche V; Fisch G; Dames S; Löffler K; Fechtner M; Arnold W; Giese K; Klippel A; Kaufmann J
Gene Ther; 2006 Aug; 13(16):1222-34. PubMed ID: 16625243
[TBL] [Abstract][Full Text] [Related]
33. Comparative studies on the efficacy of MRI contrast agents in MRA.
Weinmann HJ; Bauer H; Ebert W; Frenzel T; Radüchel B; Platzek J; Schmitt-Willich H
Acad Radiol; 2002 May; 9 Suppl 1():S135-6. PubMed ID: 12019849
[No Abstract] [Full Text] [Related]
34. [In vivo imaging of liposomal small interfering RNA (siRNA) trafficking by positron emission tomography].
Ando H; Yonenaga N; Asai T; Hatanaka K; Koide H; Tsuzuku T; Harada N; Tsukada H; Oku N
Yakugaku Zasshi; 2012; 132(12):1373-81. PubMed ID: 23208044
[TBL] [Abstract][Full Text] [Related]
35. Novel multifunctional nanoparticle mediates siRNA tumour delivery, visualisation and therapeutic tumour reduction in vivo.
Kenny GD; Kamaly N; Kalber TL; Brody LP; Sahuri M; Shamsaei E; Miller AD; Bell JD
J Control Release; 2011 Jan; 149(2):111-6. PubMed ID: 20888381
[TBL] [Abstract][Full Text] [Related]
36. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
Wen M; Li B; Ouyang Y; Luo Y; Li S
Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
[TBL] [Abstract][Full Text] [Related]
37. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
[TBL] [Abstract][Full Text] [Related]
38. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
39. Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis.
Khoury M; Louis-Plence P; Escriou V; Noel D; Largeau C; Cantos C; Scherman D; Jorgensen C; Apparailly F
Arthritis Rheum; 2006 Jun; 54(6):1867-77. PubMed ID: 16729293
[TBL] [Abstract][Full Text] [Related]
40. Anionic polymers for decreased toxicity and enhanced in vivo delivery of siRNA complexed with cationic liposomes.
Schlegel A; Largeau C; Bigey P; Bessodes M; Lebozec K; Scherman D; Escriou V
J Control Release; 2011 Jun; 152(3):393-401. PubMed ID: 21497175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]